These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 320280)

  • 21. A rabbit family of restricted high responders to the streptococcal group A-variant polysaccharide. Selective breeding narrows the isoelectric focusing spectra of dominant clones.
    Braun DG; Kjems E; Cramer M
    J Exp Med; 1973 Sep; 138(3):645-58. PubMed ID: 4727916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
    Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
    Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with Streptococcal Heme Binding Protein (Shp) Protects Mice Against Group A Streptococcus Infection.
    Zhang X; Song Y; Li Y; Cai M; Meng Y; Zhu H
    Adv Exp Med Biol; 2017; 973():115-124. PubMed ID: 28190144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
    Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
    J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptococcal vaccines revisited.
    Stollerman GH
    J Lab Clin Med; 1978 Jun; 91(6):872-80. PubMed ID: 77303
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
    De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
    Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective immunity evoked by locally administered group A streptococcal vaccines in mice.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    J Immunol; 1988 Oct; 141(8):2767-70. PubMed ID: 3049817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the active prophylaxis of streptococcal infections in experiments on monkeys].
    Köhler W; Dzhikidze EK; Kühnemund O; Wagner M; Voskanian NA
    Vestn Akad Med Nauk SSSR; 1977; (8):52-9. PubMed ID: 410188
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistence and characterization of idiotypes in pedigreed rabbits producing antibodies of restricted heterogeneity to pneumococcal polysaccharides.
    Winfield JB; Pincus JH; Mage RG
    J Immunol; 1972 May; 108(5):1278-87. PubMed ID: 4112921
    [No Abstract]   [Full Text] [Related]  

  • 30. [Primary prevention of rheumatism: the status and outlook (vaccine)].
    Rotta Y
    Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polysaccharide vaccines. I. Pneumococcal vaccines].
    Janaszek W; Wysokińska T
    Przegl Epidemiol; 1996; 50(1-2):49-54. PubMed ID: 8711160
    [No Abstract]   [Full Text] [Related]  

  • 33. Conjugate vaccines against group B Streptococcus types IV and VII.
    Paoletti LC; Kasper DL
    J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strep vaccine.
    Fox EN
    Hosp Pract; 1980 Feb; 15(2):23-4. PubMed ID: 6997177
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci.
    Kapur V; Maffei JT; Greer RS; Li LL; Adams GJ; Musser JM
    Microb Pathog; 1994 Jun; 16(6):443-50. PubMed ID: 7830531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE DETERMINATION OF ANTIBODY TO GROUP A STREPTOCOCCAL POLYSACCHARIDE IN HUMAN SERA BY HEMAGGLUTINATION.
    SCHMIDT WC; MOORE DJ
    J Exp Med; 1965 May; 121(5):793-806. PubMed ID: 14280441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The morphology of rabbit organs after immunization with streptococcal vaccine].
    Braun DG; Krause RM
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Dec; 139(1):104-17. PubMed ID: 4244221
    [No Abstract]   [Full Text] [Related]  

  • 38. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent development of the research on immunization against dental caries for controlling mutans streptococci].
    He CL; Wang D; Jin J
    Shanghai Kou Qiang Yi Xue; 2003 Jun; 12(3):215-7. PubMed ID: 14661334
    [No Abstract]   [Full Text] [Related]  

  • 40. [Curative and prophylactic immunomodulation by vaccination in mucocutaneous streptococcal infections].
    Topciu V; Teodorescu M; Sedan D
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(1-2):71-3. PubMed ID: 8963122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.